Literature DB >> 1291310

Virulence properties of erysipelas-associated group A streptococci.

A Norrby1, B Eriksson, M Norgren, C J Rönström, A C Sjöblom, K Karkkonen, S E Holm.   

Abstract

Group A streptococcal isolates (n = 53) recovered from 38 erysipelas patients in 1988 and 1990 in Sweden were analysed with respect to serotype, erythrogenic toxin production and polymorphism in the emm gene region. Serotype determination showed a dominance of type T1M1 (28.6% of the strains), but T type 8 was also prevalent (14.3%). In the majority of the strains only a low production of erythrogenic toxin A was demonstrated, while both toxin B and C production were high. Polymorphism was detected in the emm gene region of T1M1 strains at a frequency of 64%. These erysipelas associated group A streptococci were more heterogenic with respect to serotype distribution and polymorphism in the emm gene region compared to previously studied group A streptococci isolated during an outbreak of serious streptococcal infections in Sweden in 1988/1989. The material included isolates from two cases of recurrence, and typing of the isolates indicated that the patients had been infected by the same serotype as in the primary infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1291310     DOI: 10.1007/bf01961132

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

1.  Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression.

Authors:  J M Musser; A R Hauser; M H Kim; P M Schlievert; K Nelson; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  A gentle method for the lysis of oral streptococci.

Authors:  B M Chassy
Journal:  Biochem Biophys Res Commun       Date:  1976-01-26       Impact factor: 3.575

Review 3.  The rising incidence of penicillin treatment failures in group A streptococcal tonsillopharyngitis: an emerging role for the cephalosporins?

Authors:  M E Pichichero
Journal:  Pediatr Infect Dis J       Date:  1991-10       Impact factor: 2.129

4.  Current knowledge of type-specific M antigens of group A streptococci.

Authors:  R C LANCEFIELD
Journal:  J Immunol       Date:  1962-09       Impact factor: 5.422

5.  Recurrent erysipelas: predisposing factors and costs of prophylaxis.

Authors:  C Jorup-Rönström; S Britton
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

6.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

7.  Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome.

Authors:  A R Hauser; D L Stevens; E L Kaplan; P M Schlievert
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

8.  The gene sequence and some properties of protein H. A novel IgG-binding protein.

Authors:  H Gomi; T Hozumi; S Hattori; C Tagawa; F Kishimoto; L Björck
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

9.  Complete nucleotide sequence of type 6 M protein of the group A Streptococcus. Repetitive structure and membrane anchor.

Authors:  S K Hollingshead; V A Fischetti; J R Scott
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

10.  Changes in the pattern of infection caused by Streptococcus pyogenes.

Authors:  E Gaworzewska; G Colman
Journal:  Epidemiol Infect       Date:  1988-04       Impact factor: 2.451

View more
  4 in total

1.  Streptococcal DNase B is immunologically identical to superantigen SpeF but involves separate domains.

Authors:  A Eriksson; B Eriksson; S E Holm; M Norgren
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

2.  Murine model of recurrent group G streptococcal cellulitis: no evidence of protective immunity.

Authors:  A L Bisno; J M Gaviria
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

3.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).

Authors:  A Norrby-Teglund; D Newton; M Kotb; S E Holm; M Norgren
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

4.  The majority of 9,729 group A streptococcus strains causing disease secrete SpeB cysteine protease: pathogenesis implications.

Authors:  Randall J Olsen; Anjali Raghuram; Concepcion Cantu; Meredith H Hartman; Francisco E Jimenez; Susan Lee; Ashley Ngo; Kelsey A Rice; Deborah Saddington; Hannaka Spillman; Chandni Valson; Anthony R Flores; Stephen B Beres; S Wesley Long; Waleed Nasser; James M Musser
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.